NGS-based RNA-sequencing Market: Growth, Trends & Forecast
NGS-based RNA-sequencing Market is valued at USD 1,080 million in 2022, and it is projected to reach USD 6,800 million by 2033, growing at a compound annual growth rate (CAGR) of around 12.2% over the forecast period of 2023-2033.The report covers all information about the global and regional markets, including historical and future trends for market dominance, size, trades, supply, competitors, and prices, as well as key vendor information across the globe. Forecast market information, SWOT analysis, NGS-based RNA-sequencing market scenario, and feasibility study are important aspects in this report.
Companies
Covered: NGS-based RNA-sequencing Market:
·
Illumina
·
Thermo Fisher Scientific
·
Pacific Biosciences
·
Oxford Nanopore Technologies
·
BGI Group
·
Qiagen
·
F. Hoffmann-La Roche AG
·
Agilent Technologies
·
Eurofins Scientific
·
Takara Bio Inc.
The benefits of RNA sequencing over conventional technologies, the falling cost of genome sequencing, the rise in government funding for genomics projects, the expansion of RNA sequencing research, the rise in cancer cases, the growing use of NGS in cancer research, and the quick development of personalized medicine are the main factors driving this market's growth.
Global NGS-based RNA-sequencing Market Segmentation:
By Application:
• Gene
expression analysis
• Differential gene expression
• Alternative splicing analysis
• SNP detection
• Fusion gene detection
• Others
By Technology:
• Targeted Sequencing
• Whole Transcriptome Sequencing
By End-User:
• Academic and research institutes
• Biotech and pharma companies
• Contract Research Organizations (CROs)
• Others (government bodies, non-profit organizations, etc.)
Technological advancements in sequencing platforms:
Constant improvements in sequencing technology have made it possible to
create effective, portable, and user-friendly NGS sequencers that provide
precise data quickly while reducing turnaround times. In order to strengthen
their positions in this rapidly expanding sector, top businesses are thus
always focused on funding research projects for the creation of new products.
The U.S. to
Hold Lion’s Share in North America’s Market:
NGS-based RNA-sequencing Market Regional Insights:
Frequently Asked Questions:
1. What are the drivers shaping various markets?
2. What are the top performing segments, and countries / regions of each of
the markets?
3. What is the market size and growth projections?
Directly
Purchase a Copy of this NGS-based RNA-sequencing Market research
report at: https://wemarketresearch.com/purchase/ngs-based-rna-sequencing-market/1061?license=single
Asia
Pacific Pain Management Therapeutics Market
WE MARKET RESEARCH is an
established market analytics and research firm with a domain experience
sprawling across different industries. We have been working on multi-county
market studies right from our inception. Over the time, from our existence, we
have gained laurels for our deep rooted market studies and insightful analysis
of different markets.
Mr. Robbin Joseph
Corporate Sales, USA
We Market Research
USA: +1-724-618-3925
Websites: https://wemarketresearch.com/
Email: sales@wemarketresearch.com
Comments
Post a Comment